Etanercept: all 257 studies that test it

Page 3 of 3. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• Islet Transplantation in Type 1 DiabetesCompletedNCT00434811Phase 3
• Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing SpondylitisCompletedNCT00434044Phase 3
• Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic ArthritisCompletedNCT00432406Phase 4
• An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing SpondylitisCompletedNCT00421980Phase 3
• Study Evaluating Etanercept Treatment of Patients With Ankylosing SpondylitisCompletedNCT00421915Phase 3
• Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing SpondylitisCompletedNCT00418548Phase 3
• Etanercept SFP in RA PatientsCompletedNCT00413452Phase 3
• Study of TNF-Antagonism in Metabolic SyndromeCompletedNCT00409318Not applicable
• Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.CompletedNCT00393471Phase 3
• 16.0040 Ankylosing Spondylitis StudyCompletedNCT00356356Phase 3
• An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid ArthritisCompletedNCT00346294Phase 4
• Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With PsoriasisCompletedNCT00333034Phase 3
• Etanercept in Hidradenitis SuppurativaCompletedNCT00329823Phase 2
• Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to EtanerceptCompletedNCT00317538Phase 3
• Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and PsoriasisCompletedNCT00317499Phase 3
• TNF Alpha in Refractory AsthmaCompletedNCT00276029Not applicable
• Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis SubjectsCompletedNCT00252668Phase 4
• Enbrel Liquid Immunogenicity ProtocolCompletedNCT00249041Phase 3
• Phase II Trial of Enbrel in Patients With Primary Systemic AmyloidosisCompletedNCT00224393Phase 2
• Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic SyndromesCompletedNCT00217386Phase 2
• A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV DiseaseCompletedNCT00205231Not applicable
• Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid TumorsCompletedNCT00201812Phase 1
• Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaCompletedNCT00201682Phase 1/2
• Study Evaluating Etanercept and Methotrexate in Plaque PsoriasisCompletedNCT00161655Phase 4
• Study Evaluating Etanercept in Moderate to Severe AsthmaCompletedNCT00141791Phase 2
• The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host DiseaseCompletedNCT00141713Phase 2
• Study of Etanercept (Enbrel) in the Treatment of Pemphigus VulgarisCompletedNCT00135720Phase 2
• Etanercept With Tacrolimus for PsoriasisCompletedNCT00134394Phase 2
• Study of the Efficacy and Safety of Etanercept in Adults With VitiligoCompletedNCT00134368Phase 2
• Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid DisordersCompletedNCT00132418Phase 4
• Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and CachexiaTerminatedNCT00127387Phase 2/3
• Study of Etanercept in the Treatment of Psoriasis in Adult SubjectsCompletedNCT00121615Phase 3
• Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With PsoriasisCompletedNCT00116181Phase 3
• Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)CompletedNCT00115219Phase 4
• Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic SyndromeCompletedNCT00111956Phase 2/3
• Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With PsoriasisCompletedNCT00111449Phase 3
• Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult SubjectsCompletedNCT00111436Phase 3
• Enbrel® in Psoriatic ArthritisCompletedNCT00111124Phase 4
• An Evaluation of Etanercept in the Treatment of Subjects With PsoriasisCompletedNCT00111111Phase 3
• Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of PsoriasisCompletedNCT00110981Phase 4
• Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)CompletedNCT00099554Phase 4
• Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled SyringesCompletedNCT00094341Phase 4
• Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic SyndromesCompletedNCT00093366Phase 1/2
• Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected SubjectsCompletedNCT00091741Phase 1
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00063869Phase 2
• Treatment of Resistant Langerhans Cell Histiocytosis With ENBRELCompletedNCT00048373Phase 2
• Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced CancerCompletedNCT00046904Phase 3
• The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With EtanerceptCompletedNCT00034060Phase 2
• Etanercept for Non-Infectious Lung Injury Following Bone Marrow TransplantationCompletedNCT00029328Phase 1/2
• The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid ArthritisStatus unknownNCT00012506Phase 3
• Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar ExtractionCompletedNCT00006070Phase 2
• Etanercept for Wegener's GranulomatosisCompletedNCT00005007Phase 2/3
• Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)CompletedNCT00001955Phase 2
• Etanercept Therapy for Sjogren's SyndromeCompletedNCT00001954Phase 2
• Etanercept to Treat Wegener's GranulomatosisCompletedNCT00001901Phase 2
• Study of TNFR:Fc (Enbrel) in the Treatment of AsthmaCompletedNCT00001893Phase 2
• TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid ArthritisCompletedNCT00001862Phase 2

← Etanercept overview